Committed to regenerative medicine
Geistlich Pharma specializes in the regeneration of bone, cartilage and tissue. Geistlich’s regenerative medical devices aim to improve patients’ quality of life.
More than 750 employees worldwide work for Geistlich in the area of regenerative medicine. With its thirteen affiliates and 60 distribution partners, Geistlich’s medical devices and medicinal products reach around 90 markets worldwide. The twelve affiliates cover the UK, Germany, Italy, France, China, Brazil, South Korea, North America, Australia, New Zealand, India and Japan. In November 2021, Geistlich has expanded its existing offering with products of Meta Technologies S.r.l.
Two business units under one Swiss roof
Geistlich Pharma is divided into two business units:
- Geistlich Dental: Dentistry, oral and maxillofacial surgery
- Geistlich Medical: Sports Medicine, Orthopedics, Wound Care & Infectiology
The Swiss company, which has its headquarters in Wolhusen, central Switzerland, plus one other Swiss site, strives for Swiss Quality. All research and development as well as production take place at its headquarters in Wolhusen. The new build extension which opened in 2019 in Wolhusen reinforces the philosophic approach “Everything under one roof” and is further affirmation of the site. Bone and collagen have been manufactured here continuously since 1899.
The close collaboration with scientists and researchers plays a decisive role in the development of the products. Geistlich Pharma is organised into three business divisions: Geistlich Biomaterials (dental medicine), Geistlich Surgery (orthopaedics and traumatology) and Geistlich Medical (pharmaceuticals and supplementals). The company is entirely privately owned, enabling it to think and act with the long term in mind.